News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
86,291 Results
Type
Article (6766)
Company Profile (6)
Press Release (79422)
Multimedia
Podcasts (2)
Webinars (3)
Section
Business (24402)
Career Advice (393)
Deals (3211)
Drug Delivery (9)
Drug Development (8051)
Employer Resources (41)
FDA (2669)
Job Trends (1755)
News (35696)
Policy (3141)
Tag
2027 BioCapital Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
Academia (513)
Accelerated approval (6)
ADA (3)
Adcomms (4)
Allergies (19)
Alliances (6465)
ALS (25)
Alzheimer's disease (739)
Antibody-drug conjugate (ADC) (49)
Approvals (2749)
Artificial intelligence (242)
ASCO (31)
Autoimmune disease (24)
Automation (18)
Bankruptcy (36)
Best Places to Work (1542)
BIO (4)
Biosimilars (19)
BioSpace Insights (19)
Biotechnology (6)
Bladder cancer (23)
Brain cancer (18)
Breast cancer (178)
Cancer (929)
Cardiovascular disease (63)
Career advice (341)
Career pathing (2)
CAR-T (20)
CDC (2)
Cell therapy (79)
Cervical cancer (6)
Clinical research (6706)
Collaboration (342)
Commercialization (3)
Compensation (21)
Complete response letters (10)
COVID-19 (469)
CRISPR (4)
C-suite (155)
Cystic fibrosis (9)
Data (1109)
Decentralized trials (1)
Depression (16)
Dermatology (6)
Diabetes (50)
Diagnostics (1582)
Digital health (11)
Diversity (2)
Diversity, equity & inclusion (11)
Drug discovery (45)
Drug pricing (6)
Duchenne muscular dystrophy (31)
Earnings (7637)
Editorial (8)
Employer branding (6)
Employer resources (39)
Events (10437)
Executive appointments (126)
FDA (3264)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (206)
Gene editing (9)
Generative AI (16)
Gene therapy (59)
GLP-1 (121)
Government (521)
Guidances (47)
Healthcare (2717)
Hematology (10)
HIV (5)
Huntington's disease (6)
IgA nephropathy (7)
Immunology and inflammation (19)
Immuno-oncology (6)
Indications (32)
Infectious disease (492)
Inflammatory bowel disease (25)
Inflation Reduction Act (1)
Influenza (11)
Intellectual property (36)
Interviews (79)
IPO (1172)
IRA (2)
Job creations (237)
Job search strategy (269)
JPM (6)
Kidney cancer (8)
Labor market (1)
Layoffs (69)
Leadership (7)
Legal (499)
Liver cancer (21)
Longevity (5)
Lung cancer (107)
Lymphoma (31)
Machine learning (11)
Management (13)
Manufacturing (106)
Marketing (2)
MASH (28)
Medical affairs (1)
Medical device (2722)
Medtech (2761)
Mergers & acquisitions (2150)
Metabolic disorders (125)
mRNA (34)
Multiple sclerosis (62)
NASH (6)
Neurodegenerative disease (116)
Neuropsychiatric disorders (10)
Neuroscience (1008)
Neurotech (1)
NextGen: Class of 2026 (750)
Non-profit (575)
Now hiring (6)
Obesity (46)
Opinion (46)
Ovarian cancer (18)
Pain (29)
Pancreatic cancer (38)
Parkinson's disease (88)
Partnered (10)
Patents (80)
Patient recruitment (87)
Peanut (3)
People (7402)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase 1 (1854)
Phase 2 (3000)
Phase 3 (2590)
Pipeline (1431)
Policy (17)
Postmarket research (204)
Preclinical (788)
Press Release (6)
Prostate cancer (112)
Radiopharmaceuticals (210)
Rare diseases (93)
Real estate (635)
Recruiting (18)
Regulatory (2842)
Reports (8)
Research institute (426)
Resumes & cover letters (57)
Rett syndrome (3)
RNA editing (3)
RSV (1)
Schizophrenia (16)
Series A (30)
Series B (18)
Sickle cell disease (8)
Special edition (1)
Spinal muscular atrophy (30)
Sponsored (17)
Startups (376)
Stomach cancer (3)
Supply chain (9)
Tariffs (1)
The Weekly (2)
Vaccines (176)
Venture capital (9)
Weight loss (18)
Women's health (22)
Worklife (7)
Date
Today (8)
Last 7 days (45)
Last 30 days (272)
Last 365 days (3215)
2026 (2203)
2025 (3126)
2024 (4128)
2023 (5003)
2022 (8740)
2021 (7452)
2020 (6077)
2019 (5867)
2018 (4400)
2017 (3873)
2016 (3828)
2015 (4383)
2014 (3311)
2013 (2863)
2012 (3015)
2011 (3214)
2010 (2800)
Location
Africa (103)
Alabama (2)
Alaska (1)
Arizona (59)
Arkansas (5)
Asia (5181)
Australia (1032)
California (1255)
Canada (387)
China (88)
Colorado (62)
Connecticut (48)
Delaware (44)
Europe (11966)
Florida (371)
Georgia (59)
Hawaii (1)
Idaho (12)
Illinois (222)
India (9)
Indiana (102)
Iowa (2)
Japan (104)
Kansas (13)
Kentucky (6)
Louisiana (7)
Maine (14)
Maryland (103)
Massachusetts (1081)
Michigan (61)
Minnesota (98)
Mississippi (2)
Missouri (19)
Nebraska (3)
Nevada (16)
New Hampshire (22)
New Jersey (343)
New Mexico (10)
New York (421)
North Carolina (158)
North Dakota (1)
Northern California (590)
Ohio (30)
Oklahoma (2)
Oregon (10)
Pennsylvania (206)
Rhode Island (6)
South America (175)
South Carolina (28)
Southern California (543)
Tennessee (30)
Texas (405)
United States (5304)
Utah (57)
Vermont (1)
Virginia (28)
Washington D.C. (5)
Washington State (79)
West Virginia (3)
Wisconsin (29)
86,291 Results for "aspect imaging".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Voiant Expands Clinical Trial Imaging Services into Obesity and Metabolic Disease Research
Highlight: Voiant expands into obesity and metabolic disease research, helping sponsors move beyond traditional weight-loss measures with advanced body composition and metabolic imaging endpoints.
August 4, 2026
·
1 min read
Earnings
AstraZeneca Builds Obesity Pipeline On ‘Medical Aspect,’ Not Aesthetics
In an investor call Thursday, AstraZeneca CEO Pascal Soriot outlined his company’s approach to obesity drug development based on “the medical aspect” of weight loss, including driving down visceral fat.
November 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Aspect Biosystems Announces $280 Million Partnership with Government of Canada to Advance Development of Bioengineered Cellular Medicines
April 3, 2026
·
3 min read
Press Releases
Lumexa Imaging Announces Participation in Upcoming Investor Conferences
August 25, 2026
·
3 min read
Press Releases
QT Imaging Appoints Medical Imaging and Digital Health Executive Dr. Julia Albright as Chief Science Officer
July 29, 2026
·
7 min read
Press Releases
Invenio Imaging Announces Completion of Enrollment in Landmark Study of AI-Based Image Analysis for Lung Cancer
August 3, 2026
·
4 min read
Press Releases
Lumexa Imaging Announces Second Quarter 2026 Results
August 13, 2026
·
20 min read
Press Releases
Cognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA Meeting Minutes
June 24, 2026
·
8 min read
Press Releases
United Imaging Spotlights Molecular Imaging Showstoppers at SNMMI 2026
June 1, 2026
·
3 min read
Press Releases
Ventripoint Expands Subscription Access for FDA-Cleared AI Cardiac Imaging
August 12, 2026
·
9 min read
1 of 8,630
Next
